The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells-Reference-Cited by-同舟云学术

The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells

Published:2016-06-09 Issue:1 Volume:17 Page:
ISSN:1471-2164
Container-title:BMC Genomics
language:en
Short-container-title:BMC Genomics

Author:

Hansen Stine Ninel,Ehlers Natasja Spring,Zhu Shida,Thomsen Mathilde Borg Houlberg,Nielsen Rikke Linnemann,Liu Dongbing,Wang Guangbiao,Hou Yong,Zhang Xiuqing,Xu Xun,Bolund Lars,Yang Huanming,Wang Jun,Moreira Jose,Ditzel Henrik J,Brünner Nils,Schrohl Anne-Sofie,Stenvang Jan,Gupta Ramneek

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biotechnology

Link

http://link.springer.com/content/pdf/10.1186/s12864-016-2749-4

Reference58 articles.

1. Wang J, Xu B, Yuan P, Zhang P, Li Q, Ma F, Fan Y: TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy. Breast Cancer Res Treat. 2012;135:531–7.

2. Arriola E, Rodriguez-Pinilla SM, Lambros MB, Jones RL, James M, Savage K, Smith IE, Dowsett M, Reis-Filho JS: Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer. Breast Cancer Res Treat. 2007;106:181–9.

3. Du Y, Zhou Q, Yin W, Zhou L, Di G, Shen Z, Shao Z, Lu J: The role of topoisomerase IIalpha in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures. Breast Cancer Res Treat. 2011;129:839–48.

4. Di Leo A, Desmedt C, Bartlett JM, Piette F, Ejlertsen B, Pritchard KI, Larsimont D, Poole C, Isola J, Earl H, Mouridsen H, O’Malley FP, Cardoso F, Tanner M, Munro A, Twelves CJ, Sotiriou C, Shepherd L, Cameron D, Piccart M, Buyse M: HER2 and TOP2A as predictive markers for anthracycline- containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data. Lancet Oncology. 2011;12:1134–42.

5. De Laurentiis M, Cancello G, D’Agostino D, Giuliano M, Giordano A, Montagna E, Lauria R, Forestieri V, Esposito A, Silvestro L, Pennacchio R, Criscitiello C, Montanino A, Limite G, Bianco A, De Placido S. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials. J Clin Oncol. 2008;26:44–53.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorcin in Cancer Development and Chemotherapeutic Drug Resistance;Cancers;2024-08-09

2. Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines;International Journal of Molecular Sciences;2024-07-19

3. Essential Roles of Peroxiredoxin IV in Inflammation and Cancer;Molecules;2022-10-02

4. Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer;Frontiers in Pharmacology;2022-06-03

5. DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease;Pharmaceutics;2022-04-27